“…GWAS small effect sizes have been repeatedly found with disease endpoints such as type 2 diabetes [30, 31], obesity [32,33], hypertension [34], ischemic heart disease [35,36], and for physical traits such as body height [37]. However, there is some indication it may be easier to find genes and variants associated with exercise-related traits as the effect size is larger for some of them [28]. This is not a trivial issue.…”